pTCB-avelHCknob6xHis
(Plasmid
#237383)
-
PurposepTwist CMV BetaGlobin encoding avelumab heavy chain with knob Fc and 6xHis tag
-
Depositing Labs
-
Publication
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 237383 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepTwist CMV BetaGlobin
-
Backbone manufacturerTwist Bioscience
- Backbone size w/o insert (bp) 4832
- Total vector size (bp) 6260
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameavelumab heavy chain
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1428
- Promoter CMV
-
Tag
/ Fusion Protein
- 6xHis (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XhoI (not destroyed)
- 3′ cloning site NheI (not destroyed)
- 5′ sequencing primer N/A (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2022.10.26.513931 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pTCB-avelHCknob6xHis was a gift from Carolyn Bertozzi & Jessica Stark (Addgene plasmid # 237383 ; http://n2t.net/addgene:237383 ; RRID:Addgene_237383) -
For your References section:
Antibody-lectin chimeras for glyco-immune checkpoint blockade. Stark JC, Gray MA, Ibarlucea-Benitez I, Lustig M, Bond A, Cho B, Govil I, Luu T, Priestley MJ, Veth TS, Errington WJ, Bruncsics B, Ribi MK, Williams LA, Sarkar CA, Wisnovsky S, Riley NM, Morrissey MA, Valerius T, Ravetch JV, Bertozzi CR.. Nat Biotechnol 2025 10.1038/s41587-025-02884-6